The American Nurses Association (ANA) confers the Hall of Fame Award to Balik Scientist Dr. Rose Constantino for her continued commitment and invaluable contribution in the field of health care.
In their official press release, ANA President Ernest Grant emphasizes that the award is even more relevant and timely, as nurses also serve as frontliners who battle the current pandemic. “ANA is honored to celebrate the achievements of these nurses and champions, who are exemplary leaders and advocates, and whose contributions have advanced the field of nursing,” he says.
As an expert on psychiatry, mental health, and forensic nursing, Dr. Constantino is an Associate Professor at the University of Pittsburgh - School of Nursing and a Balik Scientist Program (BSP) Awardee under the Department of Science and Technology - Philippine Council for Health Research and Development (DOST-PCHRD). With the grant awarded by BSP, she pursues the project: “Assessing the HEARTS (Health Experience of Abuse, Resilience, Treatment, and Safety) of the Elderly in the Philippines”. Focused on assessing the health status and quality of life of the elderly, she initially partnered with the Centro Escolar University - Manila in 2017 for the implementation of HEARTS and moved to expand the program in partnership with the Cebu Normal University (CNU) in 2019.
Under the BSP, Dr. Constantino also works as a consultant for projects under HEARTS, acts as a mentor and evaluator of research projects on aging population, and gives lectures on (1) HEARTS in Application to Elderly; and (2) Forensic Nursing in Gerontology Issues.
“On behalf of DOST-PCHRD, we would like to congratulate Dr. Constantino in yet another feat she has achieved with the award from ANA. Her work as a Balik Scientist proves her commitment to advance the field of healthcare, and support our mission to make lives better for the Filipino,” says DOST-PCHRD Executive Director Dr. Jaime Montoya.
The Balik Scientist Program is the brain-gain initiative of the DOST which encourages Filipino scientists based abroad to return to the Philippines with the goal of sharing their expertise to help advance science and technology in the country.
The Balik Scientist Act or RA 11035 was signed into law last June 2018.
When the novel coronavirus disease (COVID-19) hit the Philippines early this year, the Ateneo Center for Computing Competency and Research (ACCCRe) of Ateneo de Manila University in collaboration with the University of the Philippines Manila - National Telehealth Center (UP-NTHC), the Department of Health-Epidemiology Bureau and the Department of Science and Technology - Philippine Council for Health Research and Development (DOST-PCHRD) recalibrated the Feasibility Analysis of Syndromic Surveillance using Spatio-temporal Epidemiological Modeler or FASSSTER to enable forecasting of estimate number of COVID-19 cases in specific areas for specific period of time, in line with the area’s health capacity. With the recalibration, FASSSTER was able to provide an evidence-based tool to the DoH, local government units (LGUs) and other healthcare facilities to mitigate potential risks brought by COVID-19 and maximize the allocation of healthcare resources.
DOST-PCHRD Executive Director Dr. Jaime C. Montoya assures the reliability of the predictions from this tool. He said, “FASSSTER was never made overnight. Developed since 2016, this tool is a product of rigorous studies and composed of credible and updated data.. Long before COVID19, this tool was already used in the surveillance of Dengue, Measles, and Typhoid.”
Initially used for Dengue, Typhoid Fever and Measles, FASSSTER is utilized for visualizing disease models and generating syndromic surveillance reports during public health crises. From 2016 to 2019, the application was deployed for use in 17 Rural Health Units (RHUs) across the country. Specifically, FASSSTER connects syndromic surveillance and event surveillance from the field to an electronic medical record, uses health information to improve on initial disease models and provides a visualization tool for decision making.
The implementation of FASSSTER and its recalibration for COVID-19 is made possible through the efforts of several teams in ADMU, namely: the Data Science and Computational Modelling Team, Mathematical Modelling Team, Data Management Team, Data Warehouse Team, Systems Development Team, and the Public Health Team. Each team is led by notable professors and scientists:
Dr. Maria Regina E. Estuar is the team leader of FASSSTER and the Data Science and Computational Modelling Team. She is a professor at the Department of Information Systems and Computer Science at ADMU. She also serves as the Executive Director of the Ateneo Center for Computing Competency and Research (ACCCRE) and is the founder of the Ateneo Social Computing Science Laboratory. In 2019, she bagged the Outstanding Women in the Nation's Service Award for Science and Technology from TOWNS Foundation Inc. for her significant contributions in strengthening the country’s S&T capacity.
Dr. Elvira de Lara-Tuprio is an expert in disease modeling through differential equations and financial mathematics, with focus on financial derivatives and risk management. She is in charge of FASSSTER’s Mathematical Modelling Team. Currently, she works as an Associate Professor for the Mathematics Department of ADMU.
Dr. Marlene M. De Leon is the team leader of the Data Management Team of FASSSTER. She is an Associate Professor in the Department of Information Systems and Computer Science of ADMU and manages Quality Assurance of Data and Information at the University.
Dr. Raymond Francis R. Sarmiento leads the Data Warehouse Team of FASSSTER. Currently, he works as the Director of the National Telehealth Center of the UP National Institutes of Health (UPNIH). He is also a Balik Scientist of the DOST who specializes in clinical and public health informatics and health data science, among others. In 2019, Dr. Sarmiento was recognized as an Outstanding Young Scientist in public health informatics by the National Academy of Science and Technology.
Mr. Christian Pulmano leads the Systems Development Team of FASSSTER. He works full-time as part of the Department of Information Systems and Computer Science of ADMU. He is also the head of the Ateneo Block Chain Laboratory (formerly AMBERLab) which received the Recognition of Excellence Award by OpenGov Asia in 2019. He is co-founder and Chief Technology Officer of BluEHR, a spin-off product from ACCCRe
Dr. Norbie Mendoza leads the Epidemiology and Public Health Team of FASSSTER. He specializes in the field of health and medical informatics.
The development of FASSSTER is part of the DOST-PCHRD’s projects under the Information and Communications Technology in Health priority area which aims to advance the country’s telehealth services and systems and public health surveillance, among others. Committed to making lives better for the Filipino, the DOST-PCHRD supports the development of health and health-related research projects outlined by the DOST’s Harmonized National Research and Development Agenda (HNRDA) and the National Unified Health Research and Development Agenda (NUHRA).
The Department of Health (DOH) and the Philippine Council for Health Research and Development (PCHRD) is pleased to announce the first call for research proposals for the Advancing Health through Evidence-Assisted Decisions with Health Policy and Systems Research (AHEAD-HPSR) Program.
Interested institutions, organizations, and researchers are invited to submit a full proposal on any of the topics listed below.
Interested institutions, organizations, and researchers are invited to submit a full proposal on any of the topics hereto attached.
Letter of Intent
Project Proposal following the PCHRD Detailed Proposal Form
Workplan Schedule (Gantt Chart of Activities)
Proposed Line-Item Budget (LIB)
Informed Consent Form (for studies involving human subjects)
Curriculum Vitae of lead proponent (Principal Investigator/Project Leader)
Duties and Responsibilities of each project personnel
Profile of the institution
Endorsement of agency head
For queries, you may contact Ms. Clarissa B. Reyes.
The 2020 Joint Research Project Call for Proposals between DOST and the Ministry of Science and Technology (MOST) of the People’s Republic of China is now open!
In pursuit of cooperation between the Department of Science and Technology (DOST) and the Ministry of Science and Technology (MOST) of the People’s Republic of China, we are calling for mutually beneficial and collaborative project proposals in any of the following identified priority areas:
A total of eight (08) new projects will be approved during this call for proposals. DOST will provide an annual funding of up to Php 8,000,000.00 for each approved research project, while MOST will provide an annual funding of up to RMB 1,000,000.00 for the Chinese counterpart. Each project should have a maximum duration of two (2) years.
For reference, below is the timeline for the 2020 DOST-MOST JRP Call for Proposals:
Deadline for submitting applications:
26 June 2020
Exchange lists of applications that meet the eligibility requirements:
By the end of June 2020
Exchange of respective review results:
By the end of September 2020
Selection decision and announcement:
By the end of October 2020
Start of project:
From January 2021 to December 2022
Submission of final reports:
Upon completion of each project
Interested parties are advised to coordinate with prospective counterpart/collaborator in China to craft the project proposals. The Filipino researcher must submit the capsule proposal to DOST through the Office of the Assistant Secretary for International Cooperation while the Chinese counterpart will submit the same to MOST for separate review and evaluation. Only proposals that are endorsed for further submission of full-blown proposals will undergo technical review and possible approval by both DOST and MOST.
Project Title: SOLIDARITY Treatment Trial: Multicenter Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Project Leader:Marissa M. Alejandria, MD, MSc Implementing Agency: National Institutes of Health- University of the Philippines Manila Duration:12 months
Despite worldwide efforts to develop a treatment against COVID-19, there is still no evidence-based medication proven effective to fight the virus.
To compare the effects of major COVID-19 treatment outcomes among hospitals globally, the World Health Organization (WHO) organized a solidarity treatment trial aimed at unifying efforts to assess any effects and provide reliable estimates of these treatments on COVID-19 cases. As one of the participating countries, the Philippines is conducting a study among 24 hospitals from Luzon, Visayas, and Mindanao. The study will test the safety and effectiveness of four repurposed drugs in treating COVID-19 compared to the standard of care being practiced in all participating hospitals.
The project is expected to provide evidence-based clinical practice guidelines for the care of COVID-19 patients and, eventually, provide evidence-based medicine against the virus. Funded by the Department of Science and Technology through the Philippine Council for Health Research and Development (DOST-PCHRD), the project has been approved for implementation last April 11, 2020 and has started enrolling patients.